Novel chinmedomics strategy for discovering effective constituents from ShenQiWan acting on ShenYangXu syndrome.
Elucidation of the efficacy of traditional Chinese medicine (TCM) is of importance for scientists of modern medicine to understand the value of TCM clinical experience, and it is necessary to have a biological language to scientifically describe the efficacy of TCM. With this background?Chinmedomics has been proposed by our team, which includes integrating serum pharmacochemistry and metabolomics technology, defining theory and research methods for expressing the efficacy of TCMs based on the biomarkers discovery of TCM syndrome and elucidating the efficacy of TCM formulae, discovering effective constituents, and finally elucidating the scientific value of TCM. In the present study, the innovative chinmedomics strategy was conducted to evaluate the therapeutic effects of ShenQiWan (SQW) acting on ShenYangXu (kidney-yang deficiency syndrome, KYDS). We analyzed the urine metabolic trajectory between the model and control groups, and identified the biomarkers by the multivariate analysis. We found that SQW caused significant restoration of abnormal metabolism of KYDs. Using the method of metabolomics, 17 potential urine biomarkers were analyzed through 4 repeated tests in our serial studies on SQW and KYDS. Under the premise of therapeutic efficacy, a total of 56 peaks were tentatively characterized in vivo by the use of serum pharmacochemistry. Correlation analysis between marker metabolites and in vivo constituents of SQW showed that 28 compositions had a close relationship with urine biomarkers of therapeutic effects, whichmight play a key role in the therapeutic effect of SQW. These compounds were imported into an online database to predict their targets. Twenty-three important potential targets were identified, which were related to the metabolism of steroid hormone, tryptophan utilization, and thyroid hormone. In conclusion, chinmedomics is a useful strategy for discovery of potentially effective constituents from complex TCM formulae.
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Xiao-Hang
XH
Zhou
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Ai-Hua
AH
Zhang
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Liang
L
Wang
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Yun-Long
YL
Tan
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Yu
Y
Guan
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Ying
Y
Han
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China.
Hui
H
Sun
National TCM Key Laboratory of Serum Pharmacochemistry, Sino-US Chinmedomics Technology Cooperation Center, Research Center of Chinmedomics (State Administration of TCM), Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin 150040, China. Electronic address: xijunwanglsls@yeah.net.
Xi-Jun
XJ
Wang
D000818:Animals; D015415:Biomarkers / Q000652:urine; D004195:Disease Models, Animal; D004365:Drugs, Chinese Herbal / Q000008:administration & dosage*; D006801:Humans; D007668:Kidney / Q000187:drug effects / Q000503:physiopathology; D007674:Kidney Diseases / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine; D008297:Male; D055432:Metabolomics / Q000379:methods*; D016711:Yang Deficiency / Q000188:drug therapy* / Q000503:physiopathology / Q000652:urine*
D015415:Biomarkers; D004365:Drugs, Chinese Herbal
Chinmedomics; Metabolomics; Serum pharmacochemistry; ShenQiWan; ShenYangXu syndrome